Immunophotonics co-founders Lu Alleruzzo, CEO and Tomas Hode, PhD, CIO, and President will attend the AngioDynamics International Life Symposium taking place November 7th to 9th in Monte Carlo.  They will engage with industry partners and clinical experts globally, focusing on the latest breakthrough technologies for surgical interventions.

Look for Lu and Tomas at this event for an opportunity to find out more about how Immunophotonics innovative approach could transform standard treatments into powerful immunotherapies with IP-001 turning every procedure into an opportunity to mobilize the body’s natural immune system against cancer.